SciProtech's Innovative Product - SARS-CoV-2 Antigen Detection Antibody Pair (Colloidal Gold Method)
Antigen Screening, Nucleic Acid Diagnosis
SARS-CoV-2 Structure and Immunodetection Antigens
The new coronavirus (SARS-CoV-2) has four main structural proteins: spike protein (Spike protein, S protein), nucleocapsid protein (Nucleocapsid, N protein), membrane protein (Membrane protein, M protein), package Membrane protein (Envelope protein, E protein). The S protein is a very important surface protein of the coronavirus and is closely related to the infectivity of the virus. The S protein contains S1, S2 and a receptor binding domain (RBD, which binds to the new coronavirus receptor ACE2). The N protein is abundant in coronaviruses with few mutations, and is a highly immunogenic protein involved in genome replication and regulation of cell signaling pathways. S protein and N protein can be used as antigens for new crown immune detection.
The Principle of Colloidal Gold Detection of New Crown Antigen:
领英推荐
Introduction of SciProtech:
The antibody discovery team of SciProtech Co., Ltd. originated from the Chinese Academy of Sciences. It has continuously undertaken the task of antibody engineering under the national "863" plan for 25 years. It is the pioneer and founder of the field of genetic engineering antibodies in China.
SciProtech has a complete full-species antibody discovery technology system, covering the key links of target preparation, antibody screening, antibody optimization and antibody evaluation. Integrate hybridoma, phage antibody library and single B cell technology to provide comprehensive and detailed solutions for the needs of different species of antibody screening and optimization.
SciProtech has three core technologies:
(1) Pharmaceutical-grade electrofusion hybridoma technology;
(2) Rapid construction of tens of billions of large antibody library technology;
(3) High-throughput/full-species antibody molecule conversion technology.
SciProtech provides high-quality antibody discovery technology services for domestic and foreign antibody drug companies, cell therapy companies, in vitro diagnostic companies and scientific research institutes. In the future, we will continue to uphold scientific concepts, empower the global antibody industry, create a "practical" antibody discovery technology platform with ingenuity, and develop "really useful" antibody products for customers.
Genfine Biotech (Beijing) Co., Ltd. is a national high-tech biotechnology enterprise integrating R&D, production, sales and technical services. As the main investment body of SciProtech, it will build SciProtech into a world-class antibody discovery technology service provider and protein reagent supplier through the integration of all aspects of resources.